Shock waves to the feet may help MS patients walk steadier
NCT ID NCT07514104
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study tested whether applying shock wave therapy to the soles of the feet could improve balance and walking in people with multiple sclerosis (MS). Fifty-four participants received the therapy three times a week for six weeks. Researchers measured changes in foot sensation, balance, and gait patterns. The goal was to see if this non-invasive treatment could help manage MS-related movement problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fırat University
Elâzığ, 23100, Turkey (Türkiye)
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Extracorporeal Shock Wave Therapy (ESWT)
What this could lead to
If it works, this could offer a non-drug way to improve balance and walking in people with multiple sclerosis.
What could go wrong
This is a small, completed study with only 54 participants. The results may not apply to everyone with MS, and the therapy may not provide lasting benefits.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.